Rapport Therapeutics

dusk parachute
Biotech

Sage CMO steps down amid pipeline struggles—Chutes & Ladders

Sage CMO steps down amid pipeline struggles. Former NIH Director Collins retires from agency. Rapport ropes in industry vet as CMO.
bullish sentiment

Why biotechs can benefit from the 'rational' IPO environment

Jan 24, 2025 10:30am
FDA stop sign

FDA places Rapport's nerve damage trial on hold

Nov 7, 2024 8:50am
Graphic image of the letters IPO in white in front of a yellow background

Rapport upsizes IPO, tacking on $32M

Jun 7, 2024 11:00am
brain neurological neurosurgery

Rapport talks up $122M IPO for proof-of-concept epilepsy trials

Jun 3, 2024 7:10am
Photo of Wall Street street sign with american flags in the background

Third Rock, J&J neuroscience spinout Rapport outlines IPO plans

May 20, 2024 5:13am